MeiraGTx Holdings plc Profile Avatar - Palmy Investing

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following…

Biotechnology
US, New York [HQ]

Lobbying Analysis

MeiraGTx Holdings plc has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of MGTX's Analysis
CIK: 1735438 CUSIP: G59665102 ISIN: KYG596651029 LEI: - UEI: -
Secondary Listings
MGTX has no secondary listings inside our databases.